← Leaderboards
Genoveffa Franchini
Basic Sciences
$170,281
Attributed
$170,281
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$170,281 · 3
By mechanism
P51$170,281 · 3
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Virus Genetics”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,964,480
- Peter B. Gilbert · Fred Hutchinson Cancer Center$132,137,683
- Barton F Haynes · Duke University$107,675,530
- James E. Gern · University Of Wisconsin-Madison$88,566,279
- David Heimbrook · Leidos Biomedical Research, Inc.$86,566,766
- Dan H. Barouch · Fred Hutchinson Cancer Center$83,705,596
Research focus
Virus GeneticsHuman T Cell Lymphotropic Virus Type 1Macaca MulattaHiv InfectionsInterleukin 2Simian Immunodeficiency VirusVirus ProteinVaccine DevelopmentMacacaNonhuman Therapy EvaluationReceptor ExpressionViral CarcinogenesisVirus AntigenActive ImmunizationDisease /Disorder ModelAids VaccinesImmune ResponseCell TransformationInfectionProtein Structure FunctionPoxviridaeReceptor BindingHuman Immunodeficiency Virus 1Biotechnology
Grant awards (21)
Understanding the Role of the Host Response in HIVSIV Infection$1,116,963
Z01 · FY2008 · CA · contact PI
T-cell Transformation by Oncoviruses$930,803
Z01 · FY2008 · CA · contact PI
Preventive and therapeutic T cell vaccines to mitigate HIV-1 replication; Preven$3,087,817
Z01 · FY2007 · CA · contact PI
T-cell Transformation by Oncoviruses$1,386,252
Z01 · FY2007 · CA · contact PI
T-cell Transformation by Oncoviruses$0
Z01 · FY2006 · BC · contact PI
Preventive and therapeutic T cell vaccines to mitigate H$0
Z01 · FY2006 · BC · contact PI
Preventive and therapeutic T cell vaccines to mitigate H$0
Z01 · FY2005 · BC
T-cell Transformation by Oncoviruses$0
Z01 · FY2005 · BC
INDUCTION OF SIV-SPECIFIC CD8+ LYMPHOCYTES$47,161
P51 · FY2004 · RR
T-cell Transformation by Oncoviruses$0
Z01 · FY2004 · BC
Combination of Vaccine Modalities to Prevent HIV-I Infec$0
Z01 · FY2004 · BC
VACCINE STRATEGIES FOR INDUCTION OF ANTI-HIV MUCOSAL IMMUNE RESPONSES$61,560
P51 · FY2003 · RR
INDUCTION OF SIV-SPECIFIC CD8+ INTRAEPITHELIAL LYMPHOCYTES$61,560
P51 · FY2003 · RR
Vaccine Modalities to Prevent HIV-I Infection$0
Z01 · FY2003 · BC
T-cell Transformation by Oncoviruses$0
Z01 · FY2003 · BC
Combination of Vaccine Modalities to Prevent HIV-I Infec$0
Z01 · FY2002 · BC
T-cell Transformation by Oncoviruses$0
Z01 · FY2002 · BC
Vaccine Modalities to Prevent HIV-I Infection$0
Z01 · FY2001 · BC
T-cell Transformation by Oncoviruses$0
Z01 · FY2001 · BC
T-cell Transformation by Oncoviruses$0
Z01 · FY2000 · BC
Combination of Vaccine Modalities to Prevent HIV-I Infection and Modeling of Ear$0
Z01 · FY2000 · BC